先进的多电解质复合物用于超快速的血液静止和血液超吸收.
Sajjad Fanaee1, Alireza Zabihihesari2, Tianqin Ning3
1School of Biomedical Engineering, Dalhousie University, Halifax, NS B3H 4R2, Canada; Department of Biomaterials & Applied Oral Sciences, Faculty of Dentistry, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Acta biomaterialia
|November 15, 2025
概括
新的静血海绵通过可调节的静电相互作用释放多酸盐 (PP) 来控制出血. 这些超吸收装置显著减少了凝血时间,并吸收了大量的液体,提高了创伤生存率.
科学领域:
- 生物材料科学 生物材料科学
- 血液静止研究 血液静止研究
- 聚合物化学 聚合物化学
背景情况:
- 出血是创伤死亡的主要原因.
- 目前的静血装置旨在控制出血,但存在局限性.
- 多酸盐 (PP) 加快血液凝固,但需要控制的输送.
研究的目的:
- 开发一种超吸收性静血装置,具有受时间控制的促凝聚物多酸盐 (PP) 释放.
- 为了研究 PP 结合和释放的机制,从修改的奇托支架.
- 评估静血海绵在控制血液流失方面的 in vitro 和 in vivo 疗效.
主要方法:
- 制造具有可调节的静电性能的修改基多海绵支架.
- 使用静电相互作用对聚酸盐 (PP) 结合和释放动学的表征.
- 在静态和动态条件下的血液凝固时间的体外评估.
- 使用大鼠肝出血模型进行静脉效能的体内评估.
主要成果:
- 静血海绵通过竞争的静电相互作用显示了PP的受控释放.
- 血液凝固时间在体外和体内减少了高达75%的时间.
- 这些海绵表现出超吸收性质,在8小时内在液体中吸收高达其干质量的25倍.
- 在体外和体外研究中观察到一致的疗效.
结论:
- 一种基于多电解质复合物的新型静血海绵有效控制出血.
- 可调节的静电相互作用使多酸盐的时间控制释放能够增强血静.
- 超吸收和快速凝固特性使这些海绵适合管理各种出血情况.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K
01:05Introduction to Hemostasis
13.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.2K
01:22Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
184
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
184
01:09Coagulation
9.5K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K